Why does peptide purity vary between batches?

Understanding batch-to-batch variation

Peptide purity can vary between batches because each synthesis run is influenced by multiple controlled and uncontrolled factors. Even when the same sequence is produced, small differences in resin performance, coupling efficiency, deprotection conditions, purification cutoffs, and analytical acceptance criteria can change the final impurity profile.

Common sources of variation include:

• Stepwise synthesis efficiency during solid-phase production
• Incomplete cleavage or side reactions that leave trace byproducts
• Purification method differences, such as HPLC gradient selection
• Analytical interpretation of chromatograms and integration settings
• Storage and transport conditions before final release

For laboratories, the key is not only the stated purity percentage, but also whether the batch is supported by a current COA, an appropriate HPLC profile, and identity confirmation such as mass spectrometry. When comparing lots, review the impurity pattern, not just the headline number. Products should be handled as research use only and are not intended for human consumption.